跳至主要内容
临床试验/NCT04383756
NCT04383756撤回早期 1 期

Utilization of Donor Whole Blood for Blood Transfusion in Deceased Donor Liver Transplantation

Vanderbilt University Medical Center2 个研究点 分布在 1 个国家开始时间: 2020年12月最近更新:
适应症

试验速览

阶段
早期 1 期
状态
撤回
试验地点
2
主要终点
Economic cost

研究概览

简要总结

We will study 40 matched patients. 20 patients will receive leukoreduced whole blood from the solid organ donor. These 20 patients will be compared to 20 historical matched controls with regards to allogenic blood product usage and other physiologic markers

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • - Recipients 18 years or older.
  • Deceased donor whole graft liver transplant recipients undergoing liver transplant starting 07/01/2020 and onwards at VUMC.
  • ABO-matched recipient and donor.
  • Donor Hb level >/= 8 g/dL
  • Recipients with negative ABO antibody screen

排除标准

  • - Pediatric recipient.
  • HBS Antigen+ donors
  • HCV NAT+ donors
  • Donors of A2 blood type
  • Donors on oral anticoagulants (except for aspirin) over the past 3 days before organ procurement

结局指标

主要结局

Economic cost

时间窗: perioperative up to 72 hours post operative

Total cost of perioperative transfusions

Use of allogenic banked blood products

时间窗: perioperative up to 72 hours post operative

Measured by the number of allogenic banked blood products used

次要结局

  • Number of Serious Adverse Events (SAEs)(Baseline to discharge (approximately 4-5 days))

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验